ÂÜÀòÂÒÂ×

Jessie Jiang possesses extensive experience in project and portfolio management within the biopharmaceutical industry, currently serving as the VP of Portfolio, Project, and Alliance Management at Arrivent Biopharma since June 2021. Prior roles include Senior Director Program Manager and Project Team Leader at Lyell Immunopharma, as well as various leadership positions at Denali Therapeutics and Genentech, where responsibilities encompassed alliance and portfolio management. Jessie's career began at Nektar Therapeutics, progressing from Senior Research Associate to Associate Project Manager. Educated with a BS in Biochemistry from the University of California, Davis, and advanced studies in Project Management from Stanford Continuing Studies, Jessie exhibits a strong foundation in both scientific and project management disciplines.